News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

From Academic Centers to Community Practice: The Next Chapter in CAR T-Cell Therapy

CAR T-Cell Therapy in 2026 and Beyond: Evolving Evidence, Expanding Indications, and the Path to Broader Access

July 13th 2026

Barriers, Practices, and the Road Ahead for CAR T-Cell Therapy in the Community Setting: A Q&A With Michael Byrne, DO

July 13th 2026

Expanding CAR T-Cell Therapy Access and Building Community Programs: A Q&A With Robert Richards, MS, MBA

July 13th 2026

Community Oncology and CAR T-Cell Therapy: A Q&A With Lucio Gordan, MD

July 13th 2026

Interview With Michael Byrne, DO: Barriers, Practices, and the Road Ahead for CAR T-Cell Therapy in the Community Setting

July 8th 2026

An interview with Michael Byrne, DO

An Interview With Robert Richards, MS, MBA: CAR T-Cell Therapy, Expanding Access and Building Community Programs

July 8th 2026

A Q&A with Robert Richards, MS, MBA

An Interview With Lucio Gordan, MD: Community Oncology and CAR T-Cell Therapy

July 8th 2026

An interview with Lucio Gordan, MD

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access